You have read all your free articles, to continue reading subscribe to read the rest of this content.
H. Lundbeck and Otsuka Pharmaceutical announce results from two phase III clinical trials evaluating the efficacy, safety and tolerability of brexpiprazole in the treatment of agitation in patients with dementia of the Alzheimer's type. The primary endpoint of both trials was change from baselineAlready a subscriber Login You have read…
Gedea Biotech has announced that all patients have been recruited for the multi-center study evaluating the clinical performance of an antibiotic-free treatment for vaginal infections. This pilot study marks the start of a clinical development program of a treatment with dual effect, targeting boAlready a subscriber Login You have read…
RhoVac announces that the first patient in the USA is included in the company's clinical phase IIb study in prostate cancer, a study entitled RhoVac-002. The first US clinic to include a patient in the study was Carolina Urologic Research Center. An international, multi-centre study BraVac is aAlready a subscriber…
The Swedish authority is initating an inspection of research projects of five pharmaceutical companies. The Data Inspection Board will among other things investigate how the companies inform participants about how their personal information will be handled and getting their approval to register tAlready a subscriber Login You have read all…
